Retinal pigment epithelial detachments in age-related macular degeneration: pathogenesis, manifestation and therapeutic progress
Dai Yining,Dong Fangtian
Department of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
Detachment of the retinal pigment epithelium is a prominent feature of many chorioretinal disease processes, in the elderly the most prevalent of which is age-related macular degeneration (AMD). Understanding the pathogenesis and subtypes of retinal pigment epithelium detachment is essential because each subtype has a specific pathogenesis, natural history, prognosis, and optimal treatment strategy.
Mrejen S, Sarraf D, Mukkamala SK, et al. Multimodal imaging of pigment epithelial detachment: a guide to evaluation[J]. Retina,2013,33(9):1735-1762.
[2]
Moore DJ, Hussain AA, Marshall J. Age-related variation in the hydraulic conductivity of Bruch's membrane[J]. Invest Ophthalmol Vis Sci,1995,36(7):1290-1297.
[3]
Starita C, Hussain AA, Patmore A, et al. Localization of the site of major resistance to fluid transport in Bruch′s membrane[J]. Invest Ophthalmol Vis Sci,1997,38(3):762-767.
[4]
Huang JD, Presley JB, Chimento MF, et al. Age-related changes in human macular Bruch′s membrane as seen by quick-freeze/deep-etch[J]. Exp Eye Res,2007,85(2):202-218.
[5]
Ambati J, Fowler BJ. Mechanisms of age-related macular degeneration[J]. Neuron,2012,75(1):26-39.
[6]
Marshall GE, Konstas AG, Reid GG, et al. Collagens in the aged human macula[J]. Graefes Arch Clin Exp Ophthalmol,1994,232(3):133-140.
[7]
Cukras C, Agrón E, Klein ML, et al. Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: age-related eye disease study report No. 28[J]. Ophthalmology,2010,117(3):489-499.
[8]
Stefansson E, Geirsdottir A, Sigurdsson H. Metabolic physiology in age related macular degeneration[J]. Prog Retin Eye Res,2011,30(1):72-80.
[9]
Pepple K, Mruthyunjaya P. Retinal pigment epithelial detachments in age-related macular degeneration: classification and therapeutic options[J]. Semin Ophthalmol,2011,26(3):198-208.
[10]
Fine SL, Hawkins B, Maguire M. Macular photocoagulation study[J]. Arch Ophthalmol,1984,102(11):1583.
[11]
Cackett P, Htoon H, Wong D, et al. Haemorrhagic pigment epithelial detachment as a predictive feature of polypoidal choroidal vasculopathy in a Chinese population[J]. Eye (Lond),2010,24(5):789-792.
[12]
Iijima H, Iida T, Imai M, et al. Optical coherence tomography of orange-red subretinal lesions in eyes with idiopathic polypoidal choroidal vasculopathy[J]. Am J Ophthalmol,2000, 129(1):21-26.
[13]
Braunstein RA, Gass JD. Serous detachments of the retinal pigment epithelium in patients with senile macular disease[J]. Am J Ophthalmol,1979,88(4):652-660.
[14]
Lommatzsch A, Heimes B, Gutfleisch M, et al. Serous pigment epithelial detachment in age-related macular degeneration: comparison of different treatments[J]. Eye (Lond),2009,23(12):2163-2168.
[15]
Gross-Jendroska M, Flaxel CJ, Schwartz SD, et al. Treatment of pigment epithelial detachments due to age-related macular degeneration with intra-ocular C3F8 injection[J]. Aust N Z J Ophthalmol,1998,26(4):311-317.
[16]
Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2[J]. Am J Ophthalmol,2001,131(5):541-560.
[17]
Ladas ID, Kotsolis AI, Rouvas AA, et al. Efficacy of photodynamic therapy in the management of occult choroidal neovascularization associated with serous pigment epithelium detachment[J]. Ophthalmologica,2007,221(5):313-319.
[18]
Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration[J]. N Engl J Med,2006,355(14):1419-1431.
[19]
Arora S, McKibbin M. One-year outcome after intravitreal ranibizumab for large, serous pigment epithelial detachment secondary to age-related macular degeneration[J]. Eye (Lond),2011,25(8):1034-1038.
[20]
Patel KH, Chow CC, Rathod R, et al. Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab[J]. Eye (Lond),2013,27(5):663-668.
[21]
Age-Related Eye Disease Study 2 Research G. Lutein+zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial[J]. JAMA,2013,309(19):2005-2015.